Association between increased body mass index and hospital admission for covid-19 in patients from a cardiovascular risk program
DOI:
https://doi.org/10.18041/2665-427X/ijeph.1.7967Keywords:
COVID-19, overweight, obesity, hospitalization, risk factors, hospital admissionAbstract
Introduction: Up to now, overweight and obesity have been described as risk factors for becoming infected, requiring hospitalization, and dying from COVID-19. However, the literature is not always consistent with these results.
Objective: To evaluate the impact of BMI >25 kg/m2 on hospital admission to manage COVID-19 disease in patients belonging to a cardiovascular risk program in the city of Cali, Colombia, during the year 2020.
Methods: Through an analytical observational study, the risk of requiring hospitalization due to SARS-CoV2 infection was evaluated in two cohorts of patients belonging to a cardiovascular risk program, including in the exposed group subjects with BMI >25 kg/m2. We calculated relative risk to assess the association between BMI and hospitalization by COVID-19, and the Mantel-Haenszel homogeneity test was used to evaluate possible confounding variables.
Results: BMI >25 kg/m2 was found as a protective factor for hospital admission (RR: 0.5; 95% CI: 0.30-0.80), without identifying modification or confusion in the outcome due to other clinical variables such as age >60 years, male sex, hypertension, DM2 or central obesity.
Conclusion: BMI >25 kg/m2 was found as a protective factor for hospital admission among adult patients belonging to a cardiovascular risk program, without identifying any modification or confusion in the outcome due to other clinical variables such as age >60 years, male sex, hypertension, DM2 or central obesity.
Downloads
References
Shi F, Wen H, Liu R, Bai J, Wang F, Mubarik S, et al. The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China. Glob Health Res Policy. 2021; 6(1): 18. doi: 10.1186/s41256-021-00200-8.
WHO. Novel Coronavirus(2019-nCoV) Situation Report – 22. Consultado: 2021 Jun 21. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf?sfvrsn=fb6d49b1_2.
Ministerio del Interior. Decreto numero 00420 del 2020 por el cual se imparten instrucciones para expedir normas en materia de orden público en virtud de la emergencia sanitaria generada por la pandemia de COVID-19. Bogotá: Ministerio del Interior; 2020;
Instituto Nacional de Salud. Módulo de datos COVID-19 en Colombia. Consultado: 2021 Aug 26. Available from: https://www.ins.gov.co/Direcciones/ONS/modelos-covid-19.
Lu Q-B, Zhang H-Y, Che T-L, Zhao H, Chen X, Li R, et al. The differential demographic pattern of Coronavirus Disease 2019 patient fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis. BMC Infect Dis. 2021; 21(1): 481. doi: 10.1186/s12879-021-06187-4.
Kim L, Garg S, O’halloran A, Whitaker M, Pham H, Anderson EJ, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US Coronavirus Disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. 2021; 72(9): e206–e214, https://doi.org/10.1093/cid/ciaa1012.
Wingert A, Pillay J, Gates M, Guitard S, Rahman S, Beck A, et al. Risk factors for severity of COVID-19: a rapid review to inform vaccine prioritisation in Canada. BMJ Open. 2021;11(5):e044684. doi: 10.1136/bmjopen-2020-044684.
Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020; 21(11): e13128. doi: 10.1111/obr.13128.
Dragon-Durey M-A, Chen X, Kirilovsky A, Hamouda NB, El Sissy C, Russick J, et al. Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity. PLoS One. 2021;16(5):e0252026. doi: 10.1371/journal.pone.0252026.
Donamou J, Touré A, Camara AY, Camara D, Camara ML, Traoré AD, et al. Predictive factors of mortality in patients with covid-19 in Guinea: Analysis of the first 140 cases admitted to intensive care unit. Pan Afr Med J. 2021;38: 205. doi: 10.11604/pamj.2021.38.205.27078.
Inoue Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, et al. Risk and protective factors related to mortality from pneumonia among middle-aged and elderly community residents: The JACC study. J Epidemiol. 2007;17(6):194–202. doi: 10.2188/jea.17.194.
Pouwels S, Ramnarain D, Aupers E, Rutjes‐weurding L, van Oers J. Obesity may not be associated with 28‐day mortality, duration of invasive mechanical ventilation and length of intensive care unit and hospital stay in critically ill patients with severe acute respiratory syndrome coronavirus‐2: A retrospective cohort st. Medicina (Kaunas). 2021; 57(7): 674. doi: 10.3390/medicina57070674.
Kooistra EJ, de Nooijer AH, Claassen WJ, Grondman I, Janssen NAF, Netea MG, et al. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients. Int J Obes. 2021;45(3):687–94. doi: 10.1038/s41366-021-00747-z.
N O, JL P, JJ L, K W. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11(2): 85–97. doi: 10.1038/nri2921.
Walkey AJ, Rice TW, Konter J, Ouchi N, Shibata R, Walsh K, et al. Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure. Crit Care Med. 2010; 38(12): 2329-34. doi: 10.1097/CCM.0b013e3181fa0561.
Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005; 165(1): 55–61. doi:10.1001/archinte.165.1.55.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA. 2020; 323(20): 2052–9. doi: 10.1001/jama.2020.6775.
Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020; 382:2372-2374. Doi: 10.1056/NEJMc2010419
Faria CF, Reis RW, Ribeiro FAC, de Souza RG, Duarte GRS, Barroso WA. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes Metab Syndr. 2020; 14(5): 809-814. doi: 10.1016/j.dsx.2020.06.016.
Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020; 28(7): 1195-1199. doi: 10.1002/oby.22831.
Chen TL, Dai Z, Mo P, Li X, Ma Z, Song S, et al. Clinical characteristics and outcomes of older patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A single-centered, retrospective study. J Gerontol A Biol Sci Med Sci. 2020; 75(9): 1788-1795. doi: 10.1093/gerona/glaa089.
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020; 323(18): 1775-1776. doi: 10.1001/jama.2020.4683.
Downloads
Published
Versions
- 2021-06-30 (2)
- 2021-06-30 (1)
Issue
Section
License
Copyright (c) 2021 Interdisciplinary Journal of Epidemiology and Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
-
NonCommercial — You may not use the material for commercial purposes.
-
NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
